Compare TMP & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TMP | ATRC |
|---|---|---|
| Founded | 1836 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.4B |
| IPO Year | 1996 | 2005 |
| Metric | TMP | ATRC |
|---|---|---|
| Price | $84.53 | $29.27 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | ★ $74.00 | $51.17 |
| AVG Volume (30 Days) | 46.3K | ★ 521.3K |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | ★ 3.15% | N/A |
| EPS Growth | ★ 126.16 | 74.74 |
| EPS | ★ 11.24 | N/A |
| Revenue | $75,742,000.00 | ★ $201,630,000.00 |
| Revenue This Year | N/A | $15.27 |
| Revenue Next Year | $7.94 | $12.21 |
| P/E Ratio | $7.58 | ★ N/A |
| Revenue Growth | N/A | ★ 15.40 |
| 52 Week Low | $56.55 | $27.26 |
| 52 Week High | $86.95 | $43.18 |
| Indicator | TMP | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 69.21 | 47.88 |
| Support Level | $72.14 | $28.60 |
| Resistance Level | $86.95 | $30.90 |
| Average True Range (ATR) | 1.76 | 1.21 |
| MACD | 0.90 | 0.18 |
| Stochastic Oscillator | 85.17 | 59.82 |
Tompkins Financial Corp is a Financial Holding Company. The company manages its operations through two business segments, consisting of banking and wealth management. It offers various products and services, including commercial and consumer banking, leasing, trust and investment management, financial planning and wealth management, and insurance. Wealth management activities include the results of the company's trust, financial planning, and wealth management services. The company generates the majority of its revenue from the Banking segment.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.